B. Metzler Seel. Sohn & Co. Ag Atri Cure, Inc. Transaction History
B. Metzler Seel. Sohn & Co. Ag
- $10 Billion
- Q3 2024
A detailed history of B. Metzler Seel. Sohn & Co. Ag transactions in Atri Cure, Inc. stock. As of the latest transaction made, B. Metzler Seel. Sohn & Co. Ag holds 31,366 shares of ATRC stock, worth $989,283. This represents 0.01% of its overall portfolio holdings.
Number of Shares
31,366
Previous 31,366
-0.0%
Holding current value
$989,283
Previous $714,000
23.11%
% of portfolio
0.01%
Previous 0.01%
Shares
6 transactions
Others Institutions Holding ATRC
# of Institutions
212Shares Held
49.7MCall Options Held
12KPut Options Held
7.2K-
Vanguard Group Inc Valley Forge, PA4.66MShares$147 Million0.0% of portfolio
-
Black Rock Inc. New York, NY4.62MShares$146 Million0.0% of portfolio
-
Alliancebernstein L.P. New York, NY3.97MShares$125 Million0.04% of portfolio
-
Hood River Capital Management LLC Palm Beach Gardens, FL2.83MShares$89.3 Million1.47% of portfolio
-
Champlain Investment Partners, LLC Burlington, VT2.79MShares$88 Million0.5% of portfolio
About AtriCure, Inc.
- Ticker ATRC
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 46,424,700
- Market Cap $1.46B
- Description
- AtriCure, Inc. develops, manufactures, and sells devices for the surgical ablation of cardiac tissue and systems, and intercostal nerves to medical centers in the United States, Europe, Asia, and internationally. The company offers Isolator Synergy Clamps, a single-use disposable radio frequency products; multifunctional pens and linear ablation...